Maastricht University Medical Centre
- Address
- P.O.Box 5800, 6202 Maastricht, The Netherlands
Maastricht University Medical Centre - Stroke & Neurovascular Research
Maastricht University Medical Centre is a leading academic medical center conducting advanced clinical research in acute cerebrovascular disease management. The center specializes in investigating innovative interventions for patients who experience incomplete response to standard mechanical thrombectomy procedures, addressing critical gaps in stroke treatment protocols.
- Acute ischemic stroke with large vessel occlusion management
- Intra-arterial thrombolytic therapy optimization
- Advanced reperfusion strategies following mechanical thrombectomy
The center's research focuses on evaluating novel intra-arterial Tenecteplase administration in patients with incomplete reperfusion and residual occlusions following initial mechanical intervention. This work aims to improve outcomes for stroke patients with large vessel occlusions who do not achieve complete revascularization with conventional endovascular techniques, representing a significant advancement in personalized acute stroke care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Maastricht University Medical Centre
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Safety and Efficacy of intra-arterial Tenecteplase for non-complete reperfusion of intracranial occlusion | Insel Gruppe AG | Phase III | Not Recruiting | Jan 2025 | Jan 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tenecteplase | 1 | Unknown | 2025-01-23 | 2025-01-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.